The purpose of this study was to develop a new delivery system capable of improving bioavailability and controlling release of hydrophilic drugs. Metformin-loaded liposomes were prepared and to improve their stability surface was coated with chitosan cross-linked with the biocompatible beta-glycerolphosphate. X-ray diffraction, differential scanning calorimetry, as well as rheological analysis were performed to investigate interactions between chitosan and beta-glycerolphosphate molecules. The entrapment of liposomes into the chitosan-beta-glycerolphosphate network was assessed by scanning electron microscopy and transmission electron microscopy. Swelling and mucoadhesive properties as well as drug release were evaluated in vitro while the drug oral bioavailability was evaluated in vivo on Wistar rats. Results clearly showed that, compared to control, the proposed microcomplexes led to a 2.5-fold increase of metformin T-max with a 40% augmentation of the AUC/D value.

Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation

MANCONI, MARIA;MANCA, MARIA LETIZIA;FADDA, ANNA MARIA;
2013-01-01

Abstract

The purpose of this study was to develop a new delivery system capable of improving bioavailability and controlling release of hydrophilic drugs. Metformin-loaded liposomes were prepared and to improve their stability surface was coated with chitosan cross-linked with the biocompatible beta-glycerolphosphate. X-ray diffraction, differential scanning calorimetry, as well as rheological analysis were performed to investigate interactions between chitosan and beta-glycerolphosphate molecules. The entrapment of liposomes into the chitosan-beta-glycerolphosphate network was assessed by scanning electron microscopy and transmission electron microscopy. Swelling and mucoadhesive properties as well as drug release were evaluated in vitro while the drug oral bioavailability was evaluated in vivo on Wistar rats. Results clearly showed that, compared to control, the proposed microcomplexes led to a 2.5-fold increase of metformin T-max with a 40% augmentation of the AUC/D value.
File in questo prodotto:
File Dimensione Formato  
Metformin 2013.pdf

Solo gestori archivio

Tipologia: versione editoriale (VoR)
Dimensione 407.14 kB
Formato Adobe PDF
407.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/104905
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 42
social impact